TCEA1
Transcription elongation factor A protein 1
Also known as: GTF2S, SII, TCEA, TCEA1_HUMAN, TF2S, TFIIS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23193
- Gene
- TCEA1
- Ensembl
- ENSG00000187735
- Chromosome
- 8
- Canonical length
- 301 aa
- Protein class
- Cancer-related genes, Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
Predicted to enable DNA binding activity; translation elongation factor activity; and zinc ion binding activity. Predicted to be involved in positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within erythrocyte differentiation and positive regulation of DNA-templated transcription. Located in nucleolus and nucleoplasm. Part of transcription factor TFIID complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
301 residues, UniProt reviewed canonical sequence.
>P23193|TCEA1
1 MEDEVVRFAK KMDKMVQKKN AAGALDLLKE LKNIPMTLEL LQSTRIGMSV NAIRKQSTDE
61 EVTSLAKSLI KSWKKLLDGP STEKDLDEKK KEPAITSQNS PEAREESTSS GNVSNRKDET
121 NARDTYVSSF PRAPSTSDSV RLKCREMLAA ALRTGDDYIA IGADEEELGS QIEEAIYQEI
181 RNTDMKYKNR VRSRISNLKD AKNPNLRKNV LCGNIPPDLF ARMTAEEMAS DELKEMRKNL
241 TKEAIREHQM AKTGGTQTDL FTCGKCKKKN CTYTQVQTRS ADEPMTTFVV CNECGNRWKF
301 CLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCEA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 116 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 116 nTPM
- tonsil: 105 nTPM
- lymph node: 91 nTPM
- liver: 84 nTPM
- bone marrow: 77 nTPM
- parathyroid gland: 75 nTPM
Single-cell type
- erythrocyte progenitors: 284 nCPM
- late spermatids: 238 nCPM
- parietal cells: 225 nCPM
- megakaryocytes: 223 nCPM
- plasma cells: 204 nCPM
- b-cells: 171 nCPM
Immune cell
- memory B-cell: 215 nTPM
- naive B-cell: 176 nTPM
- T-reg: 153 nTPM
- plasmacytoid DC: 118 nTPM
- memory CD4 T-cell: 108 nTPM
- gdT-cell: 105 nTPM
Brain region
- white matter: 72 nTPM
- spinal cord: 57 nTPM
- medulla oblongata: 57 nTPM
- basal ganglia: 56 nTPM
- hypothalamus: 55 nTPM
- cerebellum: 52 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.9
- gnomAD missense Z
- 1.38
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- erythrocyte differentiation
- positive regulation of transcription by RNA polymerase II
- transcription elongation by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, TFIIS-type
- Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type
- Transcription elongation factor S-II, central domain
- Transcription elongation factor, TFIIS
- Transcription factor IIS, N-terminal
- Transcription elongation factor, IIS-type
- TFIIS/LEDGF domain superfamily
- Transcription elongation factor S-II, central domain superfamily
- Transcription factor S-II (TFIIS)
- Transcription factor S-II (TFIIS), central domain
- TFIIS helical bundle-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCEA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCEA1 as an antibody target. Whether an autoantibody or antibody against TCEA1 could matter depends on whether native TCEA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCEA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TCEA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...